Azithromycin
- TRADE NAMES: AzaSite (Merck); Azenil; Azitrocin; Azitromax; Zeto; Zithromax (Pfizer); Zitromax; Zmax
- INDICATIONS: Infections of the upper and lower respiratory tract, skin infections, sexually transmitted diseases, conjunctivitis (ophthalmic preparations only)
- CLASS: Antibiotic, Antibiotic; macrolide, Antimicrobial, Covid-19 putative drug
- HALF-LIFE: 68 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminophylline, Antacids, Artemether/Lumefantrine, Astemizole, Atorvastatin, Betrixaban, Bromocriptine, Cabergoline, Colchicine, Coumarins, Cyclosporine, Digoxin, Droperidol, Ergotamine, Fluvastatin, Lovastatin, Methysergide, Mizolastine, Oral typhoid vaccine, Pimozide, Pravastatin, Quetiapine, Reboxetine, Rifabutin, Ritonavir, Simvastatin, Venetoclax, Warfarin
PREGNANCY CATEGORY: B
Investigated for treating COVID-19.
AzaSite is for topical ophthalmic use only (see reactions noted [Ophth] below).
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 03/09/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric